BioSpace News Archive

Lantern Pharma announced it has expanded its collaboration agreement with the Developmental Therapeutics Branch of the National Cancer Institute of the National Institutes of Health.

TCR 2 Therapeutics Inc. today announced the appointment of Rosemary Harrison, Ph.D., as Chief Business and Strategy Officer where she will be responsible for supporting a range of activities including commercial strategy, operational planning, corporate partnerships and long-term growth opportunities.

Ocugen, Inc. (NASDAQ: OCGN), and its partner, Bharat Biotech, today announced results from a study conducted at Emory University demonstrating that sera from subjects who received a booster dose of candidate vaccine COVAXIN.

Strategic Acquisition Strengthens TEAM’s Position as a Partner to Healthcare OEMs and Accelerates Growth in the Healthcare Specialty Manufacturing Market.

Expects to meet or exceed 2021 performance targets for new cell programs, Foundry revenue, and Biosecurity revenue.

Data Published in Ocular Oncology and Pathology Demonstrates Highly Accurate Performance of DecisionDx®-UM Seq for Patients with Uveal Melanoma.

Hemogenyx Pharmaceuticals will leverage Selexis’ SUREtechnology Platform™ of protein expression technologies and modular workflows.

ICON plc, (NASDAQ: ICLR), a world-leading clinical research organisation powered by healthcare intelligence, today announced its financial guidance for the year ended December 31, 2022.

NEXGEL, Inc. today announced the launch of its MEDAGEL ClearComfort Hydrogel Patch.

Transcenta Holding Limited announces that the TST001 US Phase I Trial has been selected as a Trial in Progress poster presentation at the 2022 ASCO GI conference from January 20 to 22, 2022 in San Francisco, CA; and the TST001 China Phase I trial data as a poster presentation at the International Gastric Cancer Congress, from March 6 to 9, 2022 in Houston, TX.